$420k. In process.This effort will investigate 10 patients with incisional wounds to study the safety and efficacy of the PWD’s negative pressure wound therapy function.
SBIR funding sponsored by USAMRAA $1.150 million. Preclinical study. Contract number W81XWH-14-C-0015. Phase I and II Completed.
Sponsor USAMRAA $2.9 million. Preclinical Study. BA170661. Under contracting negotiations. Expected start date January 1, 2019. In this preclinical effort a consortium of thought leaders in regenerative medicine have been assembled to study the efficacy of using the PWD to study adipose grafting, inflammation, and pixel skin grafting. Dr. Eriksson as PI will lead teams from the ISR, Northwestern, Applied Tissue and Pittsburgh. The Metis Foundation will be the Prime for this consortium.